Xylogenics, Inc., founded in 2008, is a pioneering biotechnology company headquartered in the United States, aiming to revolutionize fermentation processes. With its slogan, "Redefining Fermentation," the company focuses on the innovative utilization of modified yeast microorganisms to produce commercial chemicals from renewable, eco-friendly feedstocks.
The company's flagship product, SYMMETRRY, is set to launch in 2016, targeting over 200 starch ethanol production plants in the U.S. This product promises to enhance cost efficiency in ethanol production, marking a significant step forward in the Clean Energy sector.
Xylogenics is actively seeking strategic partnerships and service agreements with industry leaders, aiming to consolidate its position in the Biotechnology industry. The company's last recorded investment was a $300.00K Seed Round on December 20, 2010.